Latest Breaking News On - Alnylam pharmaceutical - Page 1 : comparemela.com

Aldevron Announces Strategic Partnership with Acuitas Therapeutics

Aldevron Announces Strategic Partnership with Acuitas Therapeutics
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesNorth dakotaChris barbosaMark wetzelAcuitas therapeutics incTechnology development at acuitas therapeutics incAldevron announces strategic partnershipAnnounces strategic partnershipAcuitas therapeuticsVice presidentTechnology developmentAlnylam pharmaceutical

FY2023 EPS Estimates for Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) Raised by Analyst

FY2023 EPS Estimates for Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) Raised by Analyst
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Michaelw bonneyWilliam blairQuent capitalNews ratings for alnylam pharmaceuticals dailyAlnylam pharmaceuticals stock performanceKb financial partnersAlnylam pharmaceuticalInvestment managementNeedham companyV square quantitative managementAlnylam pharmaceuticals incCapital advisors ltdWells fargo companyAlnylam pharmaceuticalsAlnylam pharmaceuticals company profileMorgan stanley

Pharmaceutical packaging - EPR Podcast 22

Pharmaceutical packaging - EPR Podcast 22
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Cornell university executive leadershipPackaging engineering at gilead sciencesAlnylam pharmaceuticalRochester institute of technologyGilead sciencesPrinting technologyVisveswaraya technological universityManu kittanakereAssociate directorPackaging engineeringMedical deviceKala pharmaceuticalRochester institutePackaging scienceCornell universityExecutive leadership

Baillie Gifford Adjusts Stake in Alnylam Pharmaceuticals

On December 1, 2023, Baillie Gifford (Trades, Portfolio), a renowned investment management firm, made a significant adjustment to its investment portfolio by reducing its stake in Alnylam Pharmaceuticals Inc (NASDAQ:ALNY). The transaction involved the sale of 1,196,042 shares, which resulted in a 14.65% decrease in Baillie Gifford (Trades, Portfolio)'s holdings in the company.

Alnylam pharmaceuticalsOther notable investors in alnylam pharmaceuticalsAlnylam pharmaceuticalJefferies groupVanguard health care fundFinancial health of alnylam pharmaceuticalsBaillie giffordGrowth rankFinancial strengthProfitability ranksConsumer cyclicalNotable investorsHealth care fundJoel greenblattAlnylam pharmaceuticalsNvestment management firm

Gearing Up to Challenge Pfizer in a Rare Disease, BridgeBio Secures Up to $1 25B

BridgeBio will receive $500 million in exchange for royalties from sales of acoramidis, a drug currently under FDA review for treating heart complications caused by the rare disease transthyretin amyloidosis. The deal also refinances lending agreements, providing BridgeBio with access to additional capital.

United statesPalo altoBristol myers squibbMani forooharBridgebio pharmaBio truseltiqBio pharmaBlue owl capitalCanada pension plan investment boardLeerink partnersSentynl therapeuticsAlnylam pharmaceuticalWeight lossMedical devicesHealthcare innovationMedcity news